Association between adverse pregnancy outcome and imbalance in angiogenic regulators and oxidative stress biomarkers in gestational hypertension and preeclampsia

BMC Pregnancy and Childbirth

Volumn 15, Issue 1, 2015, Pages

  Turpin, Cornelius A ^b   Sakyi, Samuel A ^a,c   Owiredu, William K B A ^a   Ephraim, Richard K D ^d   Anto, Enoch O ^a  

^a KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

^b KOMFO ANOKYE TEACHING HOSPITAL   (Ghana)

^c University of Ghana   (Ghana)

^d UNIVERSITY OF CAPE COAST   (Ghana)

Author keywords

[No Author keywords available]

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; PLACENTAL GROWTH FACTOR; 8-EPI-PROSTAGLANDIN F2ALPHA; ANGIOGENIC PROTEIN; ANTIOXIDANT; BIOLOGICAL MARKER; FLT1 PROTEIN, HUMAN; PLACENTA PROTEIN; PROSTAGLANDIN F2 ALPHA; VASCULOTROPIN RECEPTOR 1;

ADULT; ARTICLE; BIRTH; BLOOD SAMPLING; COHORT ANALYSIS; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS DEATH; HELLP SYNDROME; HUMAN; INFORMED CONSENT; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; OXIDATIVE STRESS; PLACENTA PREVIA; POSTPARTUM HEMORRHAGE; PREECLAMPSIA; PREGNANCY OUTCOME; PREGNANT WOMAN; PRENATAL CARE; PUERPERIUM; SOLUTIO PLACENTAE; SPECTROPHOTOMETRY; STILLBIRTH; TEACHING HOSPITAL; ANALOGS AND DERIVATIVES; BLOOD; GESTATIONAL AGE; INTRAUTERINE GROWTH RETARDATION; PLACENTA; PREGNANCY; PROSPECTIVE STUDY;

ADULT; ANGIOGENIC PROTEINS; ANTIOXIDANTS; BIOMARKERS; DINOPROST; FEMALE; FETAL GROWTH RETARDATION; GESTATIONAL AGE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; OXIDATIVE STRESS; PLACENTA; POSTPARTUM PERIOD; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY PROTEINS; PROSPECTIVE STUDIES; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84939799886     PISSN: None     EISSN: 14712393     Source Type: Journal    
DOI: 10.1186/s12884-015-0624-y     Document Type: Article

References (19)

1. Walker JJ. Pre-eclampsia. Lancet. 2000;356(9237):1260-5.
2. Suplee PD, Dawley K, Bloch JR. Tailoring peripartum nursing care for women of advanced maternal age. J Obstet Gynecol Neonatal Nurs. 2007;36(6):616-23.
3. Huang L, Sauve R, Birkett N, Fergusson D, van Walraven C. Maternal age and risk of stillbirth: a systematic review. Can Med Assoc J. 2008;178(2):165-72.
4. Palm M. Oxidative Stress, Angiogenesis and Inflammation in Normal Pregnancy and Postpartum. Acta Universitatis Upsaliensis Digital comprehensive summaries of Uppasala Dissertations from the Faculty of Medicine Uppsala ISBN 978-91-554-8314-2. 2012:753-763.
5. Petla LT, Chikkala R, Ratnakar KS, Kodati V, Sritharan V. Biomarkers for the management of pre-eclampsia in pregnant women. Indian J Med Res. 2013;138(1):60.
6. Smith GCS, Crossley JA, Aitken DA, Jenkins N, Lyall F, Cameron AD, et al. Circulating angiogenic factors in early pregnancy and the risk of preeclampsia, intrauterine growth restriction, spontaneous preterm birth, and stillbirth. Obstet Gynecol. 2007;109(6):1316-24.
7. Elkholi DGEY, Nagy HM. Maternal serum concentrations of angiogenic and antiangiogenic factors in threatened miscarriage at 7-12 weeks' gestation and the risk of adverse pregnancy outcomes. Middle East Fertility Society Journal. 2013;18(3):208-13.
8. Chen S-F, Lo L-M, Li M-J, Yeh Y-L, Hung T-H. The association between maternal oxidative stress at mid-gestation and subsequent pregnancy complications. Reprod Sci. 2012;19(5):505-12.
9. ACOG Committee on Practice Bulletins-Obstetrics. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Obstet Gynecol. 2002;99:159.
10. Kirkendall WM, Burton AC, Epstein FH, Freis ED. Recommendations for human blood pressure determination by sphygmomanometers. Circulation. 1967;36(6):980-8.
11. Schlembach D, Wallner W, Sengenberger R, Stiegler E, Mörtl M, Beckmann MW, et al. Angiogenic growth factor levels in maternal and fetal blood: correlation with Doppler ultrasound parameters in pregnancies complicated by pre-eclampsia and intrauterine growth restriction. Ultrasound Obstet Gynecol. 2007;29(4):407-13.
12. Ohkuchi A, Hirashima C, Matsubara S, Suzuki H, Takahashi K, Arai F, et al. Alterations in placental growth factor levels before and after the onset of preeclampsia are more pronounced in women with early onset severe preeclampsia. Hypertens Res. 2007;30(2):151-9.
13. Lawn JE, Gravett MG, Nunes TM, Rubens CE, Stanton C. Global report on preterm birth and stillbirth (1 of 7): definitions, description of the burden and opportunities to improve data. BMC pregnancy and childbirth. 2010;10 Suppl 1:S1.
14. World Health Organization. International statistical classification of diseases and related health problems, vol. 1: World Health Organization; 2004.
15. Sh J, Ghiyasi P, Haghani H. Risk factors related to intra uterine fetal death in Iran, A case-control study. Shiraz E-Medical journal. 2005;6:3-4.
16. Oyelese Y, Ananth CV. Placental abruption. Obstet Gynecol. 2006;108(4):1005-16.
17. Oyelese Y, Smulian JC. Placenta previa, placenta accreta, and vasa previa. Obstet Gynecol. 2006;107(4):927-41.
18. Caughey AB, Robinson JN, Norwitz ER. Contemporary diagnosis and management of preterm premature rupture of membranes. Rev Obstet Gynecol. 2008;1(1):11.
19. Ghosh SK, Raheja S, Tuli A, Raghunandan C, Agarwal S. Low Serum placental growth Factor Levels in late second trimester can act as biomarker for predicting intra uterine growth retardation in pregnancies complicated by preeclampsia Baixos niveis de plgF no segundo trimestre da gravidez. Acta obstet ginecol port. 2012;6(5):51-7.